|

Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes

RECRUITINGSponsored by Al-Nahrain University
Actively Recruiting
SponsorAl-Nahrain University
Started2025-02-20
Est. completion2025-12-10
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this prospective observational study is to investigate the impact of pre-hospital and hospital delays on the outcomes of myocardial infarction (MI) patients admitted to Al-Kadhimiya Teaching Hospital, Baghdad. The main questions it aims to answer are: How do pre-hospital delays (e.g., patient transport and first medical contact) affect clinical outcomes such as mortality, complication rates, and recovery time in MI patients? What is the influence of hospital-related delays (e.g., time to intervention or reperfusion therapy) on the prognosis of MI patients? Participants will: Be monitored for the time elapsed from symptom onset to first medical contact and subsequent time intervals during hospital care. Have their clinical outcomes, including in-hospital mortality, length of stay, and post-intervention complications, recorded and analyzed.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients who provide informed consent (or a legal representative provides consent if the patient is unable to do so).
* Patients who undergo reperfusion therapy, such as thrombolysis or percutaneous coronary intervention (PCI).
* Patients admitted to Al-Kadhimiya Teaching Hospital within 12 hours of symptom onset.

Exclusion Criteria:

* Patients with non-acute myocardial infarction (e.g., stable angina, prior MI).
* Patients with severe comorbidities (e.g., advanced cancer, end-stage renal disease) that may complicate outcome assessments or interfere with treatment protocols.
* Patients who are transferred to another facility before reperfusion therapy is initiated.
* Pregnant women or breastfeeding women.

Conditions2

Heart DiseaseMyocardial Infarction (MI)

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.